Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
6640546
Reference Type
Journal Article
Title
A physiologically based pharmacokinetic model for naphthalene with inhalation and skin routes of exposure
Author(s)
Kapraun, DF; Schlosser, PM; Nylander-French, LA; Kim, D; Yost, EE; Druwe, IL
Year
2020
Is Peer Reviewed?
1
Journal
Journal of Toxicological Sciences
ISSN:
0388-1350
EISSN:
1880-3989
Volume
177
Issue
2
Page Numbers
377-391
Language
English
PMID
32687177
DOI
10.1093/toxsci/kfaa117
Web of Science Id
WOS:000593274600007
URL
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85092802234&doi=10.1093%2ftoxsci%2fkfaa117&partnerID=40&md5=b37f628a76efa508d28f18c9bb17a453
Exit
Abstract
Naphthalene, a volatile organic compound present in moth repellants and petroleum-based fuels, has been shown to induce toxicity in mice and rats during chronic inhalation exposures. While simpler default methods exist for extrapolating toxicity points of departure from animals to humans, using a physiologically based pharmacokinetic (PBPK) model to perform such extrapolations is generally preferred. Confidence in PBPK models increases when they have been validated using both animal and human in vivo pharmacokinetic (PK) data. A published inhalation PBPK model for naphthalene was previously shown to predict rodent PK data well, so we sought to evaluate this model using human PK data. The most reliable human data available come from a controlled skin exposure study, but the inhalation PBPK model does not include a skin exposure route; therefore, we extended the model by incorporating compartments representing the stratum corneum and the viable epidermis and parameters that determine absorption and rate of transport through the skin. The human data revealed measurable blood concentrations of naphthalene present in the subjects prior to skin exposure, so we also introduced a continuous dose-rate parameter to account for these baseline blood concentration levels. We calibrated the three new parameters in the modified PBPK model using data from the controlled skin exposure study but did not modify values for any other parameters. Model predictions then fell within a factor of two of most (96%) of the human PK observations, demonstrating that this model can accurately predict internal doses of naphthalene and is thus a viable tool for use in human health risk assessment.
Keywords
PBPK model; skin model; computational fluid dynamics; CFD
Tags
IRIS
•
Naphthalene
Database Searches
PubMed
WOS
Combined data set
Data set for title/abstract screening
Data set for full text review
PBPK models
Acute toxicity studies
January 2021 Update
PubMed
WOS
PBPK Model Lit Search Aug 2022
PBPK Model Old Lit Search String (ran as test in Aug 2022)
IRIS Legacy
•
Naphthalene – Acute (2022)
Other
•
Naphthalene (2021 Evidence mapping publication)
Database Searches
PubMed
WOS
Combined data set
Data set for title/abstract screening
Data set for full text review
PBPK models
Acute toxicity studies
January 2021 Update
PubMed
WOS
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity